Stay updated on Pembrolizumab in Recurrent Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedFooter revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check45 days agoChange DetectedGastric cancer is added as a related topic and the Genetic and Rare Diseases Information Center is added as a resources entry for gastric cancer.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded a new site revision label: Revision: v3.4.2. The government funding lapse notice and the earlier Revision: v3.4.1 entry were removed.SummaryDifference0.4%

- Check59 days agoChange DetectedAdded a site-wide government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check66 days agoChange DetectedShow glossary toggle (Show glossary) was added to the page. Minor textual updates include capitalization changes to QC-related labels and the revision tag updated to v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Recurrent Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.